You see a filtered list - Keywords: Jankowski-Selection
[10]S. Bhargava, S. de la Puente-Secades, L. Schurgers, J. Jankowski,
"Lipids and lipoproteins in cardiovascular diseases: A classification", Trends Endocrinol. Metab., vol. 33, no. 6, pp. 409–423. [bibtex] [doi]
[9]V. Jankowski, M. Tölle, R. Vanholder, G. Schönfelder, M. van der Giet, L. Henning, H. Schlüter, M. Paul, W. Zidek, J. Jankowski,
"Uridine adenosine tetraphosphate: A novel endothelium- derived vasoconstrictive factor", Nat. Med., vol. 11, no. 2, pp. 223–227. [bibtex] [doi]
[8]J. Jankowski, J. Floege, D. Fliser, M. Böhm, N. Marx,
"Cardiovascular Disease in Chronic Kidney Disease", Circulation, vol. 143, no. 11, pp. 1157–1172. [bibtex] [doi]
[7]V. Jankowski, T. Saritas, M. Kjolby, J. Hermann, T. Speer, A. Himmelsbach, K. Mahr, M. A. Heuschkel, S. J. Schunk, S. Thirup, S. Winther, M. Bottcher, M. Nyegard, A. Nykjaer, R. Kramann, N. Kaesler, J. Jankowski, J. Floege, N. Marx, C. Goettsch,
"Carbamylated sortilin associates with cardiovascular calcification in patients with chronic kidney disease", Kidney Int., vol. 101, no. 3, pp. 574–584. [bibtex] [doi]
[6]H. Noels, M. Lehrke, R. Vanholder, J. Jankowski,
"Lipoproteins and fatty acids in chronic kidney disease: Molecular and metabolic alterations", Nat. Rev. Nephrol., vol. 17, no. 8, pp. 528–542. [bibtex] [doi]
[5]S. Orth-Alampour, N. Gayrard, S. Salem, S. Bhargava, V. Jankowski, B. Jover, C. Notarnicola, H. Noels, E. P. C. van der Vorst, C. Kuppe, M. Wolf, C. Goettsch, W. Theelen, H. Bruck, D. Fliser, J. Loscalzo, Z. Wu, N. Marx, W. Zidek, Ã. Argilés, J. Jankowski,
"Prevention of vascular calcification by the endogenous chromogranin A-derived mediator that inhibits osteogenic transdifferentiation", Basic Res. Cardiol., vol. 116, no. 1, pp. 57. [bibtex] [doi]
[4]E. Petra, T. He, V. Lygirou, A. Latosinska, H. Mischak, A. Vlahou, J. Jankowski,
"Urine peptidome analysis in cardiorenal syndrome reflects molecular processes", Sci. Rep., vol. 11, no. 1, pp. 16219. [bibtex] [doi]
[3]S. Salem, V. Jankowski, Y. Asare, E. Liehn, P. Welker, A. Raya-Bermudez, C. Pineda-Martos, M. Rodriguez, J. R. Muñoz-Castañeda, H. Bruck, N. Marx, F. B. Machado, M. Staudt, G. Heinze, W. Zidek, J. Jankowski,
"Identification of the Vasoconstriction-Inhibiting Factor (VIF), a Potent Endogenous Cofactor of Angiotensin II Acting on the Angiotensin II Type 2 Receptor", Circulation, vol. 131, no. 16, pp. 1426–1434. [bibtex] [doi]
[2]T. Speer, F. O. Owala, E. W. Holy, S. Zewinger, F. L. Frenzel, B. E. Stähli, M. Razavi, S. Triem, H. Cvija, L. Rohrer, S. Seiler, G. H. Heine, V. Jankowski, J. Jankowski, G. G. Camici, A. Akhmedov, D. Fliser, T. F. Lüscher, F. C. Tanner,
"Carbamylated low-density lipoprotein induces endothelial dysfunction", Eur. Heart J., vol. 35, no. 43, pp. 3021–3032. [bibtex] [doi]
[1]Z. Wu, J. Jankowski, Impact of post-translational modification on the genesis and progression of diseases. [bibtex] [doi]